Skip to main navigation Skip to search Skip to main content

The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus

  • RA de Boer
  • , FM Martens
  • , I Kuipers
  • , Frans Boomsma
  • , FLJ Visseren

Research output: Contribution to journalArticleAcademicpeer-review

10 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)74-76
Number of pages3
JournalJournal of Human Hypertension
Volume24
DOIs
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC COEUR-09

Cite this